Bruker Corp
NASDAQ:BRKR
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
48.25
94.27
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Bruker Corp
Bruker Corp
Total Current Liabilities
Bruker Corp
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bruker Corp
NASDAQ:BRKR
|
Total Current Liabilities
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Current Liabilities
$14.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Current Liabilities
$7.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Current Liabilities
$1.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Current Liabilities
$2.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Current Liabilities
$7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
|
Bruker Corp
Glance View
Bruker Corporation stands as a pivotal player in the life sciences and analytical instrument markets, renowned for its innovative technologies that empower researchers and laboratories worldwide. Founded in 1960, Bruker has consistently focused on developing advanced scientific instruments that enhance the understanding of biological processes and materials. Through its diverse portfolio, which includes high-performance mass spectrometry, nuclear magnetic resonance (NMR), and microscopy systems, Bruker addresses critical challenges in fields such as drug discovery, environmental analysis, and clinical diagnostics. With a commitment to innovation, the company is well-positioned to benefit from ongoing trends in healthcare and life sciences, promising an exciting growth trajectory for potential investors. As the global scientific community increasingly turns to precise analytics and advanced diagnostics, Bruker’s offerings align perfectly with the burgeoning demand for cutting-edge research tools. The company has cultivated strong relationships with academic institutions, government agencies, and pharmaceutical companies, ensuring a robust customer base. Furthermore, with a focus on sustainability and reducing environmental impact, Bruker is tapping into new market segments that prioritize eco-friendly solutions. With a solid financial foundation, a history of strategic acquisitions, and ongoing investments in research and development, Bruker Corporation represents a compelling opportunity for investors looking to gain exposure to the dynamic fields of life sciences and analytical technology.
See Also
What is Bruker Corp's Total Current Liabilities?
Total Current Liabilities
1.3B
USD
Based on the financial report for Sep 30, 2024, Bruker Corp's Total Current Liabilities amounts to 1.3B USD.
What is Bruker Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
8%
Over the last year, the Total Current Liabilities growth was 23%. The average annual Total Current Liabilities growth rates for Bruker Corp have been 13% over the past three years , 16% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
